Literature DB >> 19940660

Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature.

Walter S Bartynski1, Ameet R Upadhyaya, John F Boardman.   

Abstract

BACKGROUND AND
PURPOSE: Influenza A infection can precipitate encephalopathy, encephalitis, or Reye syndrome with the development of cerebral edema in children and is associated with an increased incidence of stroke in adults. The mechanism of these events is poorly understood. Posterior reversible encephalopathy syndrome (PRES) is seen in association with infection/sepsis, and cerebral vasculopathy has been demonstrated in PRES. We describe a case of PRES that develops in association with influenza A. SUMMARY OF CASE: A normotensive 65-year-old woman presented with altered mentation and nausea in the setting of a viral prodromal illness ultimately confirmed as influenza A. Posterior reversible encephalopathy syndrome developed on the second day after admission. Catheter cerebral angiogram documented vasculopathy in PRES-involved regions with areas of focal vessel dilatation and string-of-bead appearance.
CONCLUSIONS: The association between influenza A and PRES with documentation of cerebral vasculopathy suggests a common systemic vascular mechanism behind PRES and influenza-related encephalopathic edema and stroke.

Entities:  

Mesh:

Year:  2009        PMID: 19940660     DOI: 10.1097/RCT.0b013e3181993a43

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  10 in total

1.  Another rare cause of encephalopathy.

Authors:  Motaz Baibars; Robert Coker; Abdul Hamid Alraiyes; M Chadi Alraies
Journal:  BMJ Case Rep       Date:  2013-08-29

2.  Influenza A encephalopathy, cerebral vasculopathy, and posterior reversible encephalopathy syndrome: combined occurrence in a 3-year-old child.

Authors:  W S Bartynski; A R Upadhyaya; K A Petropoulou; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-24       Impact factor: 3.825

3.  Posterior reversible encephalopathy syndrome in neuro-malaria.

Authors:  Alexis Lacout; Celine Guidoux; Robert Yves Carlier
Journal:  Indian J Radiol Imaging       Date:  2010-08

4.  Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report.

Authors:  Owolabi Ogunneye; Jaime A Hernandez-Montfort; Yetunde Ogunneye; Iheanyichukwu Ogu; Daniel Landry
Journal:  J Med Case Rep       Date:  2012-03-26

Review 5.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

6.  Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis.

Authors:  Wouter J Meijer; Francisca H H Linn; Anne M J Wensing; Helen L Leavis; Debby van Riel; Corine H GeurtsvanKessel; Mike P Wattjes; Jean-Luc Murk
Journal:  JMM Case Rep       Date:  2016-12-19

7.  Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis.

Authors:  Florence X Doo; Gassan Kassim; Daniel R Lefton; Shanna Patterson; Hien Pham; Puneet Belani
Journal:  Clin Imaging       Date:  2020-07-16       Impact factor: 1.605

8.  Neurological manifestations related to Crohn's disease: a boon for the workforce.

Authors:  Reza Nemati; Somayeh Mehdizadeh; Hooman Salimipour; Ehsan Yaghoubi; Zeinab Alipour; Seyed Masoud Tabib; Majid Assadi
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-09-25

Review 9.  H1N1 encephalitis with malignant edema and review of neurologic complications from influenza.

Authors:  Paul Taylor Akins; John Belko; Timothy M Uyeki; Yekaterina Axelrod; Kenneth K Lee; James Silverthorn
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

10.  Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19.

Authors:  Sofía Lallana; Austin Chen; Manuel Requena; Marta Rubiera; Anna Sanchez; James E Siegler; Marián Muchada
Journal:  J Clin Neurosci       Date:  2021-03-23       Impact factor: 1.961

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.